Craig Bijou
Stock Analyst at B of A Securities
(3.82)
# 739
Out of 4,761 analysts
60
Total ratings
59.38%
Success rate
62.17%
Average return
Main Sectors:
Stocks Rated by Craig Bijou
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
BLCO Bausch + Lomb | Maintains: Underperform | $18 → $17 | $15.75 | +7.94% | 3 | Feb 20, 2025 | |
GMED Globus Medical | Upgrades: Neutral | $80 → $97 | $80.28 | +20.83% | 4 | Jan 9, 2025 | |
IART Integra LifeSciences Holdings | Maintains: Underperform | $26 → $18 | $21.13 | -14.81% | 13 | Oct 7, 2024 | |
ITGR Integer Holdings | Maintains: Buy | $135 → $145 | $129.87 | +11.65% | 3 | Oct 1, 2024 | |
MMSI Merit Medical Systems | Maintains: Neutral | $92 → $103 | $103.16 | -0.16% | 3 | Sep 16, 2024 | |
HAE Haemonetics | Initiates: Neutral | $85 | $63.02 | +34.88% | 1 | Sep 11, 2024 | |
PRCT PROCEPT BioRobotics | Maintains: Buy | $80 → $94 | $62.25 | +51.00% | 3 | Aug 22, 2024 | |
GEHC GE HealthCare Technologies | Maintains: Neutral | $94 → $86 | $91.09 | -5.59% | 2 | May 1, 2024 | |
COO The Cooper Companies | Initiates: Buy | $95 | $88.48 | +7.37% | 1 | Oct 30, 2023 | |
TFX Teleflex | Maintains: Neutral | $265 | $175.64 | +50.88% | 4 | Aug 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $25 | $13.02 | +92.01% | 1 | Mar 9, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $36 | $17.84 | +101.79% | 2 | Jan 18, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $23 → $45 | $7.99 | +463.20% | 3 | May 13, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $1 → $8 | $0.55 | +1,358.79% | 2 | Mar 25, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $17.67 | +69.78% | 5 | Mar 24, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $17 → $13 | $10.75 | +20.93% | 2 | Mar 24, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $48 → $42 | $17.95 | +133.98% | 3 | Feb 25, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $207 → $230 | $591.79 | -61.13% | 1 | Jan 10, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $190 → $230 | $382.78 | -39.91% | 4 | Jul 26, 2019 |
Bausch + Lomb
Feb 20, 2025
Maintains: Underperform
Price Target: $18 → $17
Current: $15.75
Upside: +7.94%
Globus Medical
Jan 9, 2025
Upgrades: Neutral
Price Target: $80 → $97
Current: $80.28
Upside: +20.83%
Integra LifeSciences Holdings
Oct 7, 2024
Maintains: Underperform
Price Target: $26 → $18
Current: $21.13
Upside: -14.81%
Integer Holdings
Oct 1, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $129.87
Upside: +11.65%
Merit Medical Systems
Sep 16, 2024
Maintains: Neutral
Price Target: $92 → $103
Current: $103.16
Upside: -0.16%
Haemonetics
Sep 11, 2024
Initiates: Neutral
Price Target: $85
Current: $63.02
Upside: +34.88%
PROCEPT BioRobotics
Aug 22, 2024
Maintains: Buy
Price Target: $80 → $94
Current: $62.25
Upside: +51.00%
GE HealthCare Technologies
May 1, 2024
Maintains: Neutral
Price Target: $94 → $86
Current: $91.09
Upside: -5.59%
The Cooper Companies
Oct 30, 2023
Initiates: Buy
Price Target: $95
Current: $88.48
Upside: +7.37%
Teleflex
Aug 3, 2023
Maintains: Neutral
Price Target: $265
Current: $175.64
Upside: +50.88%
Mar 9, 2022
Maintains: Buy
Price Target: $30 → $25
Current: $13.02
Upside: +92.01%
Jan 18, 2022
Maintains: Buy
Price Target: $43 → $36
Current: $17.84
Upside: +101.79%
May 13, 2020
Reiterates: Overweight
Price Target: $23 → $45
Current: $7.99
Upside: +463.20%
Mar 25, 2020
Maintains: Overweight
Price Target: $1 → $8
Current: $0.55
Upside: +1,358.79%
Mar 24, 2020
Maintains: Neutral
Price Target: $60 → $30
Current: $17.67
Upside: +69.78%
Mar 24, 2020
Reiterates: Overweight
Price Target: $17 → $13
Current: $10.75
Upside: +20.93%
Feb 25, 2020
Maintains: Neutral
Price Target: $48 → $42
Current: $17.95
Upside: +133.98%
Jan 10, 2020
Reiterates: Overweight
Price Target: $207 → $230
Current: $591.79
Upside: -61.13%
Jul 26, 2019
Maintains: Neutral
Price Target: $190 → $230
Current: $382.78
Upside: -39.91%